Growing community of inventors

Torre le Nocelle, Italy

Elvira Luongo

Average Co-Inventor Count = 14.99

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Elvira Luongo ↔ Antonio Calignano (1 patent)Elvira Luongo ↔ Giovanna La Rana (1 patent)Elvira Luongo ↔ Maria Grazia Rimoli (1 patent)Elvira Luongo ↔ Rosario Cuomo (1 patent)Elvira Luongo ↔ Gianpiero Boatto (1 patent)Elvira Luongo ↔ Enrico Abignente (1 patent)Elvira Luongo ↔ Daniela Melisi (1 patent)Elvira Luongo ↔ Annalisa Curcio (1 patent)Elvira Luongo ↔ Oscar Sasso (1 patent)Elvira Luongo ↔ Giovanni Sarnelli (1 patent)Elvira Luongo ↔ Roberto Russo (1 patent)Elvira Luongo ↔ Maria Nieddu (1 patent)Elvira Luongo ↔ Carla Cirillo (1 patent)Elvira Luongo ↔ Salvatore De Lucia (1 patent)Elvira Luongo ↔ Oscar Sasso (0 patent)Elvira Luongo ↔ Roberto Russo (0 patent)Elvira LuongoElvira Luongo (1 patent)Antonio CalignanoAntonio Calignano (5 patents)Giovanna La RanaGiovanna La Rana (3 patents)Maria Grazia RimoliMaria Grazia Rimoli (1 patent)Rosario CuomoRosario Cuomo (1 patent)Gianpiero BoattoGianpiero Boatto (1 patent)Enrico AbignenteEnrico Abignente (1 patent)Daniela MelisiDaniela Melisi (1 patent)Annalisa CurcioAnnalisa Curcio (1 patent)Oscar SassoOscar Sasso (1 patent)Giovanni SarnelliGiovanni Sarnelli (1 patent)Roberto RussoRoberto Russo (1 patent)Maria NiedduMaria Nieddu (1 patent)Carla CirilloCarla Cirillo (1 patent)Salvatore De LuciaSalvatore De Lucia (1 patent)Oscar SassoOscar Sasso (0 patent)Roberto RussoRoberto Russo (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Other (1 from 832,812 patents)

2. Stewart Italia Srl (1 from 1 patent)

3. Calignano, Antonio (0 patent)

4. Cuomo, Rosario (0 patent)

5. Boatto, Gianpiero (0 patent)

6. Rimoli, Maria Grazia (0 patent)


1 patent:

1. 8551958 - Galactosylated pro-drugs of non-steroidal anti-inflammatories with improved pharmacokinetic characteristics and reduced toxicity of the starting drug

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/19/2025
Loading…